Pharmaceutical kit for migraine headache treatment

Abstract

A pharmaceutical kit for treating migraine headaches and method of preparing the kit that includes a therapeutically effective dosage of pharmaceutical compounds used in the treatment of migraine headache. The pharmaceutical kit is manufactured with a predetermined number of dosage units of migraine treating pharmaceutical compounds. Additionally the kit provides all components necessary for the administering of the drugs in a safe and convenient manner. An aspect of the pharmaceutical kit may include injections and nasal sprays that are fast acting for relief of the migraine sufferer. A preferred pharmaceutical kit with only oral dosage units of drugs may be provided as an attachment to a water bottle.

I claim:  
     
         1 . A method for preparing a pharmaceutical kit for treating migraine headaches, said method comprising: 
 packaging in a container a therapeutically effective dosage of a serotonin level elevating pharmaceutical compound used in the treatment of migraine;    packaging in said container a therapeutically effective dosage of a prostaglandin inhibiting pharmaceutical compound used in the treatment of migraine;    packaging in said container a therapeutically effective dosage of a dopamine blocking pharmaceutical compound used in the treatment of migraine;    packaging with said container a vessel of water, said vessel of water having an upper portion and a lower portion, and for use in administering the pharmaceutical compounds which are to be orally administered; and    packaging in said container instructions for usage of the pharmaceutical compounds which it contains wherein a convenient container comprising a plurality of the pharmaceutical compounds for the treatment of migraine headaches is provided.    
     
     
         2 . The method for preparing a kit for treating migraine headaches as claimed in  claim 1 , wherein said packaging in said container a therapeutically effective dosage of the serotonin level elevating pharmaceutical compound comprises packaging at least one stat dose pen of injectable Sumatriptan in said container.  
     
     
         3 . The method for preparing a pharmaceutical kit for treating migraine headaches as claimed in  claim 1 , wherein said packaging in said container a therapeutically effective dosage of the serotonin level elevating pharmaceutical compound comprises packaging in said container a predetermined number of dosage units comprising a triptan selected from the group consisting of Sumatriptan, Rizatriptan, Zolmitriptan, and Almotriptan.  
     
     
         4 . The method for preparing a kit for treating migraine headaches as claimed in  claim 3 , wherein any one of the Sumatriptan dosage units comprises Sumatriptan in the range of 50 mg to 100 mg.  
     
     
         5 . The method for preparing a kit for treating migraine headaches as claimed in  claim 3 , wherein any one of the Rizatriptan dosage units comprises Rizatriptan in the range of 5 mg to 10 mg.  
     
     
         6 . The method for preparing a kit for treating migraine headaches as claimed in  claim 3 , wherein any one of the Zolmitriptan dosage units comprises Zolmitriptan in the range of 2.5 mg to 5 mg.  
     
     
         7 . The method for preparing a kit for treating migraine headaches as claimed in  claim 3 , wherein any one of the Almotriptan dosage units comprises Almotriptan in the range of 6.25 mg to 12.5 mg.  
     
     
         8 . The method for preparing a kit for treating migraine headaches as claimed in  claim 1 , wherein said packaging in said container a therapeutically effective dosage of the serotonin level elevating pharmaceutical compound comprises packaging a predetermined number of nasal spray devices containing Sumatriptan in said container.  
     
     
         9 . The method for preparing a kit for treating migraine headaches as claimed in  claim 8 , wherein any one of the Sumatriptan containing nasal spray devices comprises Sumatriptan in the range of 5 mg to 20 mg.  
     
     
         10 . The method for preparing a kit for treating migraine headaches as claimed in  claim 1 , wherein said packaging in said container a therapeutically effective dosage of the dopamine blocking pharmaceutical compound comprises packaging in said container a predetermined number of dosage units comprising a dopamine blocking pharmaceutical compound selected from the group consisting of Metoclopramide, and Prochlorperazine.  
     
     
         11 . The method for preparing a kit for treating migraine headaches as claimed in  claim 10 , wherein any one of the Metoclopramide dosage units comprises Metoclopramide in the range of 5 mg to 10 mg.  
     
     
         12 . The method for preparing a kit for treating migraine headaches as claimed in  claim 10 , wherein any one of the Prochlorperazine dosage units comprises Prochlorperazine in the range of 5 mg to 10 mg.  
     
     
         13 . The method for preparing a kit for treating migraine headaches as claimed in  claim 1 , wherein said packaging in said container a therapeutically effective dosage of the prostaglandin inhibiting pharmaceutical compound comprises packaging in said container a predetermined number of dosage units comprising a prostaglandin inhibiting pharmaceutical compound selected from the group consisting of Ibuprofen, Naproxyn, Acetaminophen, and Acetylsalicylic Acid.  
     
     
         14 . The method for preparing a kit for treating migraine headaches as claimed in  claim 13 , wherein any one of the Ibuprofen dosage units comprises Ibuprofen in the range of 400 mg to 800 mg.  
     
     
         15 . The method for preparing a kit for treating migraine headaches as claimed in  claim 13 , wherein any one of the Naproxyn dosage units comprises Naproxyn in the range of 500 mg to 750 mg.  
     
     
         16 . The method for preparing a kit for treating migraine headaches as claimed in  claim 13 , wherein any one of the Acetaminophen dosage units comprises Acetaminophen in the range of 250 mg to 750 mg.  
     
     
         17 . The method for preparing a kit for treating migraine headaches as claimed in  claim 13 , wherein any one of the Acetylsalicylic Acid dosage units comprises Acetylsalicylic Acid in the range of 325 mg to 500 mg.  
     
     
         18 . The method for preparing a kit for treating migraine headaches as claimed in  claim 1 , wherein said including with said container comprises packaging in said container the vessel of water.  
     
     
         19 . The method for preparing a kit for treating migraine headaches as claimed in  claim 1 , wherein said including with said container comprises attaching said container to the vessel of water.  
     
     
         20 . The method for preparing a kit for treating migraine headaches as claimed in  claim 19 , wherein said attaching said container to the vessel of water further comprises coupling said container to the lower portion of the vessel of water.  
     
     
         21 . A pharmaceutical kit, manufactured to include a complete regimen of components and pharmaceutical compounds necessary for treating migraine headache comprising: 
 a) a container including a therapeutically effective dosage of a plurality of pharmaceutical compounds used in the treatment of migraine;    b) a vessel of water packaged with said container, said vessel of water having an upper portion and a lower portion, and being used for administering of the pharmaceutical compounds which are to be orally administered; and    c) instructions for the safe and effective use of the pharmaceutical kit for treating the migraine headache.    
     
     
         22 . The pharmaceutical kit for treating migraine headache as claimed in  claim 21 , further comprising at least one injection device having a therapeutically effective dosage of Sumatriptan, said injection device being included in said container for injection of said Sumatriptan below the skin of a user.  
     
     
         23 . The pharmaceutical kit for treating migraine headache as claimed in  claim 22 , further comprising an alcohol swab packet included in said container, said alcohol swab packet being used for preparation of the user's skin associated with the administering of the Sumatriptan which is to be injected.  
     
     
         24 . The pharmaceutical kit for treating migraine headache as claimed in  claim 21 , further comprising at least one nasal spray device having a therapeutically effective dosage of Sumatriptan, said nasal spray device being included in said container for administering of said Sumatriptan through the nasal passages of a user.  
     
     
         25 . The pharmaceutical kit for treating migraine headache as claimed in  claim 21 , further comprising separate labeled packaging for each of the plurality of pharmaceutical compounds, said separate labeled packaging identifying the pharmaceutical compound which it contains.  
     
     
         26 . The pharmaceutical kit for treating migraine headache as claimed in  claim 25 , wherein said plurality of pharmaceutical compounds comprises: 
 at least two 100 mg oral dosage units of Sumatriptan;    at least two 50 mg oral dosage units of Sumatriptan;    at least two 10 mg oral dosage units of Metoclopromide HCL; and    at least two oral dosage units comprising a prostaglandin inhibiting pharmaceutical compound selected from the group consisting of Ibuprofen and Naproxyn.    
     
     
         27 . The pharmaceutical kit for treating migraine headache as claimed in  claim 26 , wherein each oral dosage unit of Ibuprofen comprises an 800 mg dose.  
     
     
         28 . The pharmaceutical kit for treating migraine headache as claimed in  claim 26 , wherein each oral dosage unit of Naproxyn comprises a 500 mg dose.  
     
     
         29 . The pharmaceutical kit for treating migraine headache as claimed in  claim 2   1 , wherein the vessel of water packaged with said container is attached to the container to provide a convenient, self contained migraine headache treatment kit.  
     
     
         30 . The pharmaceutical kit for treating migraine headache as claimed in  claim 29 , further comprising: 
 the vessel of water having a cylindrical shape including threading on the lower portion of the vessel of water; and    the container having a cylindrical shape with an outer side wall and an inner side wall, said inner side wall having threading complementary to the threading on the lower portion of the vessel of water, thereby providing a coupling for attaching the container to the vessel of water.    
     
     
         31 . The pharmaceutical kit for treating migraine headache as claimed in  claim 29 , further wherein the vessel of water attached to the container comprises an integrally manufactured, unitary member having a revolving cover with a cutout window and hinge pin for providing access to the pharmaceutical kit contents.